Skip to main content

Table 2 Laboratory data

From: Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease

 

Before treatment

10 weeks after treatment

20 weeks after treatment

Remission patients (n = 26)

   

Haemoglobin Mean g/l (range g/l)

135 (97-164)

134 (95-154)

137 (117-162)

Mean white cell count x10/1 (range)

7.8 (1.8-15.6)

7.1 (2.4-15.8)

6.8 (0.0-12.6)

Albumin Mean g/l (range g/l)

39.4 (33.0-50.0)

39.8 (34.0-45.0)

40.3 (31.0-48.0)

CRP N 10 mg/l or over (total)

3 (23)

3 (23)

2 (22)

Responded patients (n = 8)

   

Haemoglobin Mean g/l (range g/l)

135 (100-162)

127 (107-156)

130 (113-150)

Mean white cell count x10/1 (range)

12.5 (9.7-17.2)

8.9 (6.0-11.3)

8.6 (3.8-10.8)

Albumin Mean g/l (range g/l)

34.8 (29.0-41.0)

37.6 (33.0-42.0)

36.7 (32.0-39.0)

CRP N 10 mg/l or over (total)

3 (8)

2 (7)

3 (7)

Non response patients (n = 6)

   

Haemoglobin Mean g/l (range g/l)

120 (82-164)

122 (93-146)

131 (112-153)

Mean white cell count x10/1 (range)

8.9 (4.8-24.3)

8.3 (5.4-19.7)

10.5 (4.6-21.6)

Albumin Mean g/l (range g/l)

39.0 (35.0-42.0)

37.3 (32.0-41.0)

37.5 (34.0-41.0)

CRP N 10 mg/l or over (total)

3 (6)

2 (6)

3 (5)

  1. Before treatment only white cell count differed significantly (p = 0.004) between the three groups (remission/response/non-responders). At 20 weeks after treatment, however, as white cell count still differed significantly between the groups (p = 0.038), so did Albumin (p = 0.038) and C-Reactive Protein (p = 0.021).
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us